Adam Jaffé is a Paediatric Respiratory Consultant at Sydney Children’s Hospital, Associate Director of Research for Sydney Children’s Hospitals Network, Randwick and the John Beveridge Professor and Head of the Discipline of Paediatrics at the University of New South Wales. He trained partly in Sydney, but mostly in London and gained his thesis in Gene Therapy for Children with Cystic Fibrosis from Imperial College, University of London. Adam is chairman of the NSW Department of Health, Aiming for Asthma Improvement in Children Program and Chairman of the Young Lungs rare disease program of the Lung Foundation Australian. He is also on the medical and scientific advisory boards of Asthma Australia, Rare Voices Australia as well as the Cystic Fibrosis Australia Data Registry Committee.
His research career centres around translational research specifically aimed at improving child health outcomes. He established the British Paediatric Orphan Lung Disease Registry (BPOLD) and the Australasian Registry Network for Orphan Lung Disease (ARNOLD) which were set up to raise awareness and the profile of rare diseases such as Orphan Lung.
He is author of more than 150 publications and has been associated with over $6 million in grant awards, including three current National Health and Medical Research Council (NHMRC) grants as Chief Investigator.